# Evaluation of Safety and Efficacy of the S.M.A.R.T. RADIANZ™ Vascular Stent System in the Treatment of Iliac and Femoropopliteal Lesions Via Transradial Access

Study · id `cardio:ct-nct05399680` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05399680](<https://clinicaltrials.gov/study/NCT05399680>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05399680

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 151 participants.

## Technical summary

Registry record NCT05399680. Allocation not applicable; no masking; primary purpose treatment. Start 2022-06-29 (actual); primary completion 2023-09-22 (actual). Results posted on 2025-08-11.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 151 participants (enrolled count; ClinicalTrials.gov record NCT05399680, source copy `cardio:ctgov-nct05399680-2025-08-11`, retrieved 2026-10-31)
- Started: 2022-06-29 (actual) (ClinicalTrials.gov record NCT05399680, source copy `cardio:ctgov-nct05399680-2025-08-11`, retrieved 2026-10-31)
- Primary completion: 2023-09-22 (actual) (ClinicalTrials.gov record NCT05399680, source copy `cardio:ctgov-nct05399680-2025-08-11`, retrieved 2026-10-31)
- Completion: 2023-11-13 (actual) (ClinicalTrials.gov record NCT05399680, source copy `cardio:ctgov-nct05399680-2025-08-11`, retrieved 2026-10-31)
- Results first posted: 2025-08-11 (ClinicalTrials.gov record NCT05399680, source copy `cardio:ctgov-nct05399680-2025-08-11`, retrieved 2026-10-31)
- Countries: Austria; Belgium; France; Italy; Spain; Switzerland (ClinicalTrials.gov record NCT05399680, source copy `cardio:ctgov-nct05399680-2025-08-11`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05399680-2025-08-11`, retrieved 2026-10-31)

## The registry's words

- Brief title: Evaluation of Safety and Efficacy of the S.M.A.R.T. RADIANZ™ Vascular Stent System in the Treatment of Iliac and Femoropopliteal Lesions Via Transradial Access
- Acronym: RADIANCY
- Condition: Peripheral Arterial Disease
- Intervention (Device): S.M.A.R.T. RADIANZ™ Vascular Stent System
- Intervention (Device): BRITE TIP RADIANZ™ Guiding Sheath
- Intervention (Device): SABERX RADIANZ™ PTA Balloon Catheter
- Lead sponsor: Cordis US Corp.
- Lead sponsor class: INDUSTRY
- Collaborator: Qserve
- Collaborator class: INDUSTRY
- Collaborator: NAMSA
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Cordis US Corp. (`cardio:org-cordis-us-corp`)

## Provenance

Content hash: e1c617891cbbb577e928fbff013d14072a484bdfd994bdacd8f0285161aa29f7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
